Potent cough suppression by physiologically active substance in human plasma

Norio Akaike, Yushi Ito, Sachie K. Ogawa, Megumi Maeda, Masahito Wakita, Kazuo Takahama, Tetsuro Noguchi, Shintaro Kamei, Takayoshi Hamamoto, Misako Umehashi, Hiroaki Maeda

Research output: Contribution to journalArticle

Abstract

Human plasma contains wide variety of bioactive proteins that have proved essential in therapeutic discovery. However, many human plasma proteins remain orphans with unknown biological functions. Evidences suggest that some plasma components target the respiratory system. In the present study we adapted heparin affinity chromatography to fractionate human plasma for functional bioassay. Fractions from pooled human plasma yielded particular plasma fractions with strong cough suppressing effects. Purification yielded a fraction that was finally identified as an activated blood coagulation factor XIa (fXIa) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI/TOF-MS). The fraction almost completely suppressed coughs induced by either chemical or mechanical stimulation applied to larynx or bifurcation of guinea-pig trachea. Cough suppressing effect of the fraction and commercially available fXIa were one million times stronger than codeine and codeine only partially suppressed the mechanically triggered coughing in animal model. Recent reviews highlighted prominent shortcomings of current available antitussives, including narcotic opioids such as codeine and their unpleasant or intolerable side effects. Therefore, safer and more effective cough suppressants would be welcome, and present findings indicate that fXIa in human plasma as a very promising, new therapeutic candidate for effective antitussive action.

Original languageEnglish (US)
Pages (from-to)145-155
Number of pages11
JournalGeneral Physiology and Biophysics
Volume33
Issue number2
DOIs
StatePublished - Jan 1 2014

Fingerprint

Cough
Factor XIa
Antitussive Agents
Codeine
Orphaned Children
Blood Coagulation Factors
Narcotics
Larynx
Tandem Mass Spectrometry
Trachea
Affinity Chromatography
Liquid Chromatography
Biological Assay
Respiratory System
Opioid Analgesics
Heparin
Blood Proteins
Mass Spectrometry
Guinea Pigs
Lasers

Keywords

  • Cough suppressing factor
  • Factor XIa
  • Human plasma

ASJC Scopus subject areas

  • Biophysics
  • Physiology

Cite this

Potent cough suppression by physiologically active substance in human plasma. / Akaike, Norio; Ito, Yushi; Ogawa, Sachie K.; Maeda, Megumi; Wakita, Masahito; Takahama, Kazuo; Noguchi, Tetsuro; Kamei, Shintaro; Hamamoto, Takayoshi; Umehashi, Misako; Maeda, Hiroaki.

In: General Physiology and Biophysics, Vol. 33, No. 2, 01.01.2014, p. 145-155.

Research output: Contribution to journalArticle

Akaike, N, Ito, Y, Ogawa, SK, Maeda, M, Wakita, M, Takahama, K, Noguchi, T, Kamei, S, Hamamoto, T, Umehashi, M & Maeda, H 2014, 'Potent cough suppression by physiologically active substance in human plasma', General Physiology and Biophysics, vol. 33, no. 2, pp. 145-155. https://doi.org/10.4149/gpb-2013083
Akaike, Norio ; Ito, Yushi ; Ogawa, Sachie K. ; Maeda, Megumi ; Wakita, Masahito ; Takahama, Kazuo ; Noguchi, Tetsuro ; Kamei, Shintaro ; Hamamoto, Takayoshi ; Umehashi, Misako ; Maeda, Hiroaki. / Potent cough suppression by physiologically active substance in human plasma. In: General Physiology and Biophysics. 2014 ; Vol. 33, No. 2. pp. 145-155.
@article{fb7992c3032046ddbe744aff4cbf9519,
title = "Potent cough suppression by physiologically active substance in human plasma",
abstract = "Human plasma contains wide variety of bioactive proteins that have proved essential in therapeutic discovery. However, many human plasma proteins remain orphans with unknown biological functions. Evidences suggest that some plasma components target the respiratory system. In the present study we adapted heparin affinity chromatography to fractionate human plasma for functional bioassay. Fractions from pooled human plasma yielded particular plasma fractions with strong cough suppressing effects. Purification yielded a fraction that was finally identified as an activated blood coagulation factor XIa (fXIa) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI/TOF-MS). The fraction almost completely suppressed coughs induced by either chemical or mechanical stimulation applied to larynx or bifurcation of guinea-pig trachea. Cough suppressing effect of the fraction and commercially available fXIa were one million times stronger than codeine and codeine only partially suppressed the mechanically triggered coughing in animal model. Recent reviews highlighted prominent shortcomings of current available antitussives, including narcotic opioids such as codeine and their unpleasant or intolerable side effects. Therefore, safer and more effective cough suppressants would be welcome, and present findings indicate that fXIa in human plasma as a very promising, new therapeutic candidate for effective antitussive action.",
keywords = "Cough suppressing factor, Factor XIa, Human plasma",
author = "Norio Akaike and Yushi Ito and Ogawa, {Sachie K.} and Megumi Maeda and Masahito Wakita and Kazuo Takahama and Tetsuro Noguchi and Shintaro Kamei and Takayoshi Hamamoto and Misako Umehashi and Hiroaki Maeda",
year = "2014",
month = "1",
day = "1",
doi = "10.4149/gpb-2013083",
language = "English (US)",
volume = "33",
pages = "145--155",
journal = "General Physiology and Biophysics",
issn = "0231-5882",
publisher = "Slovak Academy of Sciences",
number = "2",

}

TY - JOUR

T1 - Potent cough suppression by physiologically active substance in human plasma

AU - Akaike, Norio

AU - Ito, Yushi

AU - Ogawa, Sachie K.

AU - Maeda, Megumi

AU - Wakita, Masahito

AU - Takahama, Kazuo

AU - Noguchi, Tetsuro

AU - Kamei, Shintaro

AU - Hamamoto, Takayoshi

AU - Umehashi, Misako

AU - Maeda, Hiroaki

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Human plasma contains wide variety of bioactive proteins that have proved essential in therapeutic discovery. However, many human plasma proteins remain orphans with unknown biological functions. Evidences suggest that some plasma components target the respiratory system. In the present study we adapted heparin affinity chromatography to fractionate human plasma for functional bioassay. Fractions from pooled human plasma yielded particular plasma fractions with strong cough suppressing effects. Purification yielded a fraction that was finally identified as an activated blood coagulation factor XIa (fXIa) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI/TOF-MS). The fraction almost completely suppressed coughs induced by either chemical or mechanical stimulation applied to larynx or bifurcation of guinea-pig trachea. Cough suppressing effect of the fraction and commercially available fXIa were one million times stronger than codeine and codeine only partially suppressed the mechanically triggered coughing in animal model. Recent reviews highlighted prominent shortcomings of current available antitussives, including narcotic opioids such as codeine and their unpleasant or intolerable side effects. Therefore, safer and more effective cough suppressants would be welcome, and present findings indicate that fXIa in human plasma as a very promising, new therapeutic candidate for effective antitussive action.

AB - Human plasma contains wide variety of bioactive proteins that have proved essential in therapeutic discovery. However, many human plasma proteins remain orphans with unknown biological functions. Evidences suggest that some plasma components target the respiratory system. In the present study we adapted heparin affinity chromatography to fractionate human plasma for functional bioassay. Fractions from pooled human plasma yielded particular plasma fractions with strong cough suppressing effects. Purification yielded a fraction that was finally identified as an activated blood coagulation factor XIa (fXIa) using liquid chromatography-tandem mass spectrometry (LC-MS/MS) and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry (MALDI/TOF-MS). The fraction almost completely suppressed coughs induced by either chemical or mechanical stimulation applied to larynx or bifurcation of guinea-pig trachea. Cough suppressing effect of the fraction and commercially available fXIa were one million times stronger than codeine and codeine only partially suppressed the mechanically triggered coughing in animal model. Recent reviews highlighted prominent shortcomings of current available antitussives, including narcotic opioids such as codeine and their unpleasant or intolerable side effects. Therefore, safer and more effective cough suppressants would be welcome, and present findings indicate that fXIa in human plasma as a very promising, new therapeutic candidate for effective antitussive action.

KW - Cough suppressing factor

KW - Factor XIa

KW - Human plasma

UR - http://www.scopus.com/inward/record.url?scp=84904901373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904901373&partnerID=8YFLogxK

U2 - 10.4149/gpb-2013083

DO - 10.4149/gpb-2013083

M3 - Article

C2 - 24448372

AN - SCOPUS:84904901373

VL - 33

SP - 145

EP - 155

JO - General Physiology and Biophysics

JF - General Physiology and Biophysics

SN - 0231-5882

IS - 2

ER -